We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STLA icon
26
Stellantis
STLA
$16.5B
$122M 0.66%
6,801,134
+4,645,551
+216% +$68.5M
HYG icon
27
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$121M 0.66%
1,388,300
+1,238,800
+829% +$106M
NSTG
28
DELISTED
NanoString Technologies, Inc.
NSTG
$120M 0.65%
1,796,081
+1,507,848
+523% +$75.7M
HD icon
29
Home Depot
HD
$332B
$115M 0.62%
434,097
+75,904
+21% +$20.9M
IWM icon
30
CALL
iShares Russell 2000 ETF
IWM
$80.9B
$104M 0.57%
532,000
-1,469,400
-73% -$257M
SKX
31
DELISTED
Skechers
SKX
$103M 0.56%
2,871,493
+1,163,023
+68% +$39.6M
PYPL icon
32
PayPal
PYPL
$49.5B
$98.4M 0.53%
420,262
+324,361
+338% +$67.2M
SAM icon
33
Boston Beer
SAM
$1.88B
$96.4M 0.52%
96,923
-11,945
-11% -$11.5M
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$95.9M 0.52%
3,015,732
+3,355
+0.1% +$88.2K
NTRA icon
35
Natera
NTRA
$37.5B
$90.7M 0.49%
+911,254
New +$76.1M
DHR icon
36
Danaher
DHR
$135B
$86.2M 0.47%
437,955
+318,231
+266% +$63.8M
BLDP
37
Ballard Power Systems
BLDP
$874M
$84.3M 0.46%
3,604,162
+1,815,566
+102% +$33.4M
QQQ icon
38
CALL
Invesco QQQ Trust
QQQ
$455B
$83.5M 0.45%
266,100
+57,700
+28% +$16.9M
QQQ icon
39
PUT
Invesco QQQ Trust
QQQ
$455B
$83.1M 0.45%
265,000
+93,000
+54% +$27.3M
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$81.4M 0.44%
370,606
-57,793
-13% -$12.5M
RCL icon
41
Royal Caribbean
RCL
$78.7B
$81.2M 0.44%
1,087,161
+1,016,746
+1,444% +$70.9M
TMUS icon
42
T-Mobile US
TMUS
$193B
$79.7M 0.43%
590,963
-439,448
-43% -$54.3M
ELV icon
43
Elevance Health
ELV
$81.9B
$76.3M 0.41%
237,692
+62,478
+36% +$19.2M
VCIT icon
44
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$76.2M 0.41%
+784,488
New +$75.6M
BMY icon
45
Bristol-Myers Squibb
BMY
$127B
$75.5M 0.41%
1,217,725
+847,514
+229% +$52.1M
TWST icon
46
Twist Bioscience
TWST
$5.62B
$74.5M 0.4%
527,582
-59,372
-10% -$6.59M
MU icon
47
Micron Technology
MU
$1.04T
$74.1M 0.4%
+985,051
New +$59.4M
GOOG icon
48
Alphabet (Google) Class C
GOOG
$3.9T
$74M 0.4%
845,120
-846,900
-50% -$71.4M
DAVA icon
49
Endava
DAVA
$141M
$73.3M 0.4%
955,646
+341,207
+56% +$23.1M
ARVN icon
50
Arvinas
ARVN
$518M
$73.3M 0.4%
863,107
+766,932
+797% +$26.4M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.